More than 13,000 bottles of a common blood pressure medication are being recalled nationwide, according to the Food and Drug Administration (FDA).1

On Sept. 17, the FDA gave the recall the second-highest risk level, Class II, for a low chance of serious health consequences but a risk of temporary or reversible effects. The bottles of chlorthalidone, a prescription diuretic, were initially recalled on Sept. 3 due to “failed dissolution specifications,” which can impact the effectiveness of the pills.

Which Medication Was Recalled?

The recalled drugs, manufactured by Inventia Healthcare Limited, can be identified with the following:

• Product description: Chlorthalidone tablets, 25 mg, Rx only
• Size: 100 tablets per bottle
• NDC: 64980-599-01
• Batch code: RISA24002
• Expiration date: 04/2027
• Affected quantity: 13,567 bottles

This situation follows another recall of chlorthalidone from Inventia in June, including more than 11,000 bottles with failed dissolution specifications.

What You Should Do

Contact your doctor or pharmacist for the best course of action if your bottle of chlorthalidone is affected by the recall.

Class II recalls may pose health risks, but stopping a medication suddenly can sometimes be riskier, Jennifer Young, PharmD, BCPS, CSP, lead medication safety specialist at the Institute for Safe Medication Practices, previously told HEALTH.

“While recall notifications can be frightening,” she said, “it’s important to contact your healthcare provider right away for advice before making any changes to your medication routine.”